- Home
- CDNA vs HDL Comparison
CDNA vs HDL Comparison
Compare CDNA & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- HDL
- Stock Information
- Founded
- CDNA 1998
- HDL 2016
- Country
- CDNA United States
- HDL Singapore
- Employees
- CDNA N/A
- HDL N/A
- Industry
- CDNA Medical Specialities
- HDL Restaurants
- Sector
- CDNA Health Care
- HDL Consumer Discretionary
- Exchange
- CDNA Nasdaq
- HDL Nasdaq
- Market Cap
- CDNA 1.0B
- HDL 1.2B
- IPO Year
- CDNA 2014
- HDL 2024
- Fundamental
- Price
- CDNA $19.49
- HDL $19.45
- Analyst Decision
- CDNA Buy
- HDL
- Analyst Count
- CDNA 6
- HDL 0
- Target Price
- CDNA $30.33
- HDL N/A
- AVG Volume (30 Days)
- CDNA 982.3K
- HDL 2.3K
- Earning Date
- CDNA 07-30-2025
- HDL 08-26-2025
- Dividend Yield
- CDNA N/A
- HDL N/A
- EPS Growth
- CDNA N/A
- HDL 110.82
- EPS
- CDNA 1.07
- HDL 0.06
- Revenue
- CDNA $346,421,000.00
- HDL $789,766,000.00
- Revenue This Year
- CDNA $13.31
- HDL $17.95
- Revenue Next Year
- CDNA $15.46
- HDL $13.32
- P/E Ratio
- CDNA $17.54
- HDL $33.92
- Revenue Growth
- CDNA 25.92
- HDL 10.91
- 52 Week Low
- CDNA $14.09
- HDL $13.94
- 52 Week High
- CDNA $34.84
- HDL $30.00
- Technical
- Relative Strength Index (RSI)
- CDNA 57.30
- HDL N/A
- Support Level
- CDNA $18.64
- HDL N/A
- Resistance Level
- CDNA $19.84
- HDL N/A
- Average True Range (ATR)
- CDNA 0.83
- HDL 0.00
- MACD
- CDNA -0.05
- HDL 0.00
- Stochastic Oscillator
- CDNA 69.64
- HDL 0.00
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.